IFIH1 and dermatomyositis: In summary, anti-MDA-5 autoantibodies show discriminative potential to differentiate DM following SARS-CoV 2 mRNA vaccination, with MDA-5-positive DM suspected to be pathomechanistically related via an MDA-5-MVAS-mediated type 1 interferon response to mRNA vaccine application.